FrancophonIA/ELRC3.0 huggingface dataset:
English: ProQuad with Solvent for reconstitution supplied in a Pre-filled syringe: Powder in a vial (glass) with a stopper (butyl rubber) and solvent in a pre-filled syringe (glass) with attached needle with plunger stopper (chlorobutyl rubber) and needle shield (natural rubber) in a pack size of 1 and 10.
Croatian: Prašak u bočici (staklo) s čepom (butil guma) i otapalo u napunjenoj štrcaljki (staklo) s pričvršćenom iglom s čepom klipa (klorobutil guma) i štitnikom za iglu (prirodna guma) u pakiranju od 1 i 10.
English: 10 vials (powder) + 10 pre-filled syringes without needle (solvent).
Croatian: 10 bočica (prašak) + 10 napunjenih štrcaljki bez igle (otapalo).
English: Powder in a vial (glass) with a stopper (butyl rubber) and solvent in a vial (glass) with stopper (chlorobutyl rubber) in a pack size of 1 and 10.
Croatian: Prašak u bočici (staklo) s čepom (butil guma) i otapalo u bočici (staklo) s čepom (klorobutil guma) u pakiranju od 1 i 10.
English: Bronchial spasm, Bronchitis, Epistaxis, Pneumonitis (see section 4.3), Pneumonia, Pulmonary congestion, Rhinitis, Sinusitis, Sore throat
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja kašalj, kongestija nosa, respiratorna kongestija, rinoreja manje često astma, plućna kongestija, poremećaj sinusa, kihanje, piskanje pri disanju rijetko bronhospazam, bronhitis, epistaksa, pneumonitis (vidjeti dio 4.3), pneumonija, plućna kongestija, rinitis, sinusitis, grlobolja nepoznato
English: The only vaccine related injection-site adverse reaction that was more frequent among recipients of ProQuad than among recipients of Varicella Vaccine live (Oka/Merck) and the measles, mumps, and rubella vaccine manufactured by Merck & Co. Inc. was rash at the injection site.
Croatian: Jedina nuspojava na mjestu primjene injekcije povezana s cjepivom koja je bila češća među djecom koja su primila ProQuad nego među djecom koja su primila živo cjepivo protiv varičele (Oka/Merck) i cjepivo protiv morbila, parotitisa i rubele proizvođača Merck & Co.
English: 10 vials (powder) + 10 pre-filled syringes (solvent)+ 10 needles.
Croatian: 10 bočica (prašak) + 10 napunjenih štrcaljki (otapalo) + 10 igala.
English: EU/1/05/323/008 - pack of 1 EU/1/05/323/009 - pack of 10 EU/1/05/323/012 - pack of 20
Croatian: EU/1/05/323/008 - pakiranje od 1 EU/1/05/323/009 - pakiranje od 10 EU/1/05/323/012 - pakiranje od 20
English: EU/1/05/323/005 - pack of 1 EU/1/05/323/006 - pack of 10 EU/1/05/323/007 - pack of 20
Croatian: EU/1/05/323/005 - pakiranje od 1 EU/1/05/323/006 - pakiranje od 10 EU/1/05/323/007 - pakiranje od 20
English: Acne, Clammy skin, Exfoliative dermatitis, Drug eruption, Exanthema, Henoch-Schönlein purpura, Livedo reticularis, Papular rash, Pruritus, Skin discolouration, Skin lesion, Zosteriform rash
Croatian: ‡, urtikarija, virusni egzantem, ekcem, eritem manje često akne, znojna i ljepljiva koža, eksfolijativni dermatitis, medikamentozna erupcija, egzantem, Henoch-Schönleinova purpura, livedo retikularis, papularni osip, pruritus, promjene boje kože, kožne lezije, zosteriformni osip rijetko multiformni eritem, herpes simpleks, impetigo, panikulitis, purpura, induracija kože, Stevens-Johnsonov sindrom, opekline od sunca nepoznato
English: 20 vials (powder) + 20 pre-filled syringes (solvent)+ 40 needles.
Croatian: 20 bočica (prašak) + 20 napunjenih štrcaljki (otapalo) + 40 igala.
English: EU/1/05/323/001 - pack of 1 EU/1/05/323/002 - pack of 10
Croatian: EU/1/05/323/001 - pakiranje od 1 EU/1/05/323/002 - pakiranje od 10
English: Extravasation
Croatian: Doziranje
English: Varicella caused by vaccine strain was observed in post-marketing use with Varicella Vaccine live (Oka/Merck).
Croatian: U razdoblju nakon stavljanja u promet živog cjepiva protiv varičele (Oka/Merck), opažene su varičele uzrokovane sojem iz cjepiva.
English: 20 vials (powder) + 20 pre-filled syringes (solvent)+ 20 needles.
Croatian: 20 bočica (prašak) + 20 napunjenih štrcaljki (otapalo) + 20 igala.
English: 10 vials (powder) + 10 pre-filled syringes with needle (solvent).
Croatian: 10 bočica (prašak) + 10 napunjenih štrcaljki sa iglom (otapalo).
English: ProQuad can be given at the same time as other childhood vaccines such as Prevenar, and/or hepatitis A vaccine, or with vaccines containing diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, inactivated poliomyelitis, or hepatitis B. A different place for the injection will be used for each vaccine.
Croatian: A ili s drugim cjepivima protiv difterije, tetanusa, acelularnog pertusisa, tipa B Haemophilusa influenzae, poliomijelitisa (inaktivirano cjepivo) ili hepatitisa B.
English: 10 vials (powder) + 10 pre-filled syringes (solvent)+ 20 needles.
Croatian: 10 bočica (prašak) + 10 napunjenih štrcaljki (otapalo) + 20 igala.
English: 1 vial (powder) + 1 pre-filled syringe without needle (solvent).
Croatian: 1 jednodozna bočica (prašak) + 1 napunjena štrcaljka bez igle (otapalo).
English: 1 vial (powder) + 1 pre-filled syringe with needle (solvent).
Croatian: 1 bočica (prašak) + 1 napunjena štrcaljka sa iglom (otapalo).
English: Abdominal pain upper, Abnormal faeces, Constipation, Flatulence, Nausea, Salivation increase, Stomatitis, Teething
Croatian: Poremećaji probavnog sustava proljev, povraćanje često bol u gornjem dijelu abdomena, promijenjena stolica, konstipacija, flatulencija, mučnina, pojačano slinjenje, stomatitis, izbijanje zuba rijetko bolovi u abdomenu, hematohezija, ulkus u ustima nepoznato
English: Dermatitis (including contact, atopic, and diaper rash), Heat rash, Rubella-like rash
Croatian: ‡, osip, osip sličan varičeli često dermatitis (uključujući kontaktni, atopijski i pelenski osip), osip od vrućine, osip sličan rubeli
English: 1 Enders' Edmonston strain (live, attenuated)........ not less than 3.00 log10 CCID50*
Croatian: 1, soj Enders' Edmonston ..............ne manje od 3,00 log10 CCID50* živi, atenuirani virus parotitisa
English: 1 Enders' Edmonston strain (live, attenuated)........not less than 3.00 log10 CCID50*
Croatian: 1, soj Enders' Edmonston ...............ne manje od 3,00 log10 CCID50* živi, oslabljeni virus parotitisa
English: However, post-exposure prophylaxis for varicella and measles has been demonstrated with Varicella Vaccine live (Oka/Merck) and the measles-containing vaccines manufactured by Merck & Co., Inc., respectively.
Croatian: Međutim, pokazalo se da živo cjepivo protiv varičele (Oka/Merck) pruža profilaksu protiv varičele nakon izlaganja i da cjepiva proizvođača Merck & Co., Inc. koja sadrže virus morbila pružaju profilaksu protiv morbila nakon izlaganja.
English: Withdraw the entire content of the solvent vial into a syringe.
Croatian: Izvucite cjeli sadržaj bočice s otapalom u štrcaljku.
English: Phenol red
Croatian: ≥10 ELISA
English: ProQuad powder and solvent for suspension for injection in a pre-filled syringe Measles, mumps, rubella and varicella vaccine (live)
Croatian: ProQuad Prašak i otapalo za suspenziju za injekciju u napunjenoj štrcaljki Cjepivo protiv morbila, parotitisa, rubele i varičele, živo
English: Measles virus
Croatian: živi, atenuirani virus rubele
English: ProQuad Powder and solvent for suspension for injection Measles, mumps, rubella and varicella vaccine (live)
Croatian: ProQuad prašak i otapalo za suspenziju za injekciju Cjepivo protiv morbila, parotitisa, rubele i varičele, živo
English: Measles, mumps, rubella and varicella vaccine (live).
Croatian: Cjepivo protiv morbila, parotitisa, rubele i varičele, živo.
English: Each infusion should last between 30 and 60 minutes.
Croatian: Svaka infuzija treba trajati između 30 i 60 minuta.
English: Treatment lasts from 5 to 14 days.
Croatian: Terapija traje od 5 do 14 dana.
English: By blocking the production of new proteins, the bacteria cannot multiply and they eventually die.
Croatian: Ako je inhibirana proizvodnja novih proteina, bakterije se ne mogu množiti i naposljetku umiru.
English: In all of the studies, the main measure of effectiveness was the number of patients whose infection was cured.
Croatian: U svim ispitivanjima glavna mjera djelotvornosti bio je broj bolesnika čije su infekcije izliječene.
English: Doses are lower in patients with severe liver problems.
Croatian: Doze su manje u bolesnika s ozbiljnim problemima jetre.
English: Tygacil tigecycline
Croatian: Tygacil tigeciklin
English: The European Commission granted a marketing authorisation valid throughout the European Union for Tygacil on 24 April 2006.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Tygacil na snazi u Europskoj uniji od 24. travnja 2006.
English: The length of treatment depends on where the infection is, how severe it is, and the patient's response to treatment.
Croatian: Dužina terapije ovisi o tome gdje se nalazi infekcija, koliko je ozbiljna i je li bolesnik odgovorio na terapiju.
English: In children above eight years of age, treatment is only given after consulting with a doctor with appropriate experience in the management of infectious diseases, and should be given as an infusion over a period of 60 minutes.
Croatian: Kod djece starije od osam godina, terapija se primjenjuje samo nakon savjetovanja s liječnikom s odgovarajućim iskustvom u liječenju infektivnih bolesti i treba se primjenjivati kao infuzija tijekom razdoblja od 60 minuta.
English: What measures are being taken to ensure the safe and effective use of Tygacil?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Tygacil?
English: Other information about Tygacil:
Croatian: Ostale informacije o lijeku Tygacil:
English: Why has Tygacil been approved?
Croatian: Zašto je Tygacil odobren?
English: Before using Tygacil, doctors should consider official guidance on the appropriate use of antibiotics.
Croatian: Prije primjene lijeka Tygacil liječnici trebaju proučiti službene smjernice o odgovarajućoj primjeni antibiotika.
English: It works by blocking the bacteria's ribosomes, the parts of the cell where new proteins are made.
Croatian: Djeluje inhibirajući ribosome bakterija, dijelove stanica u kojima se stvaraju novi proteini.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Tygacil.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet te preporuke o uvjetima za primjenu lijeka Tygacil.
English: Tygacil should be used only when other antibiotics are not suitable.
Croatian: Tygacil se smije koristiti samo ako antibiotici nisu primjereni.
English: Tygacil has been compared with other antibiotics in four main studies.
Croatian: Tygacil je uspoređen s drugim antibioticima u četiri glavna ispitivanja.
English: Patients allergic to tetracycline antibiotics may also be allergic to Tygacil.
Croatian: Bolesnici koji su alergični na tetraciklin mogu biti također alergični na Tygacil.
English: This document is a summary of the European Public Assessment Report (EPAR) for Tygacil.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Tygacil.
English: What is the risk associated with Tygacil?
Croatian: Koji su rizici povezani s lijekom Tygacil?
English: Although there are few data in children, studies suggest that Tygacil can be a treatment alternative for complicated skin and soft tissue or abdominal infections, with bacteria resistant to other antibiotics.
Croatian: Iako ima malo podataka za djecu, ispitivanja ukazuju na to da lijek Tygacil može biti alternativna terapija za komplicirane kožne infekcije i infekcije mekog tkiva ili abdominalne infekcije bakterijama otpornim na druge antibiotike.
English: Tygacil must not be used in people who are hypersensitive (allergic) to tigecycline or any of the other ingredients.
Croatian: Tygacil se ne smije primjenjivati u osoba koje su preosjetljive (alergične) na tigeciklin ili na bilo koju drugu pomoćnu tvar.
English: Tygacil is used to treat adults and children older than eight years with complicated infections of the skin and soft tissue (the tissue below the skin), but not foot infections in people with diabetes.
Croatian: Tygacil se koristi za liječenje odraslih osoba i djece starije od osam godina s kompliciranim infekcijama kože i mekog tkiva (tkiva ispod kože), no ne i nožnih infekcija kod osoba s dijabetesom.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tygacil, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Tygacil nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: It contains the active substance tigecycline.
Croatian: Sadrži djelatnu tvar tigeciklin.
English: The CHMP decided that Tygacil's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: CHMP je odlučio da koristi lijeka Tygacil nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
English: In adults, the recommended dose of Tygacil is a starting dose of 100 mg, followed by 50 mg every 12 hours for five to 14 days.
Croatian: Kod odraslih osoba preporučena doza lijeka Tygacil je početna doza od 100 mg, nakon čega slijedi 50 mg svakih 12 sati tijekom pet do 14 dana.
English: The full EPAR for Tygacil can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Tygacil nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports Više informacija o terapiji lijekom Tygacil pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: In children from 12 to 18 years a dose of 50 mg is given every 12 hours for a period of 5 to 14 days.
Croatian: Kod djece u dobi od 12 do 18 godina doza od 50 mg daje se svakih 12 sati tijekom razdoblja od 5 do 14 dana.
English: In the study looking at diabetic foot infections, Tygacil was less effective than ertapenem: 78% of the patients receiving Tygacil were cured, compared with 83% of those receiving ertapenem.
Croatian: U ispitivanju kojim su istražene infekcije stopala povezane s dijabetesom, Tygacil je bio manje djelotvoran od ertapenema: 78 % bolesnika koji su primili lijek Tygacil bilo je izliječeno, u usporedbi s 83 % onih koji su primali ertapenem.
English: In children from 8 to 12 years old a dose of 1.2 mg per kilogram body weight is given by infusion into a vein every twelve hours, up to a maximum dose of 50 mg every 12 hours.
Croatian: Kod djece u dobi od 8 do 12 godina doza od 1,2 mg po kilogramu tjelesne težine treba se davati infuzijom u venu svakih dvanaest sati do maksimalne doze od 50 mg svakih 12
English: The list of bacteria against which Tygacil is active can be found in the summary of product characteristics (also part of the EPAR).
Croatian: Popis bakterija protiv kojih Tygacil djeluje dostupan je u sažetku opisa svojstava lijeka (također dio EPAR-a).
English: A risk management plan has been developed to ensure that Tygacil is used as safely and effectively as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Tygacil.
English: The active substance in Tygacil, tigecycline, belongs to a group of antibiotics called ‘glycylcyclines'.
Croatian: Djelatna tvar lijeka Tygacil, tigeciklin, ubraja se u skupinu antibiotika naziva „glicilciklini”.
English: In the four main studies, Tygacil was as effective as the comparator antibiotics.
Croatian: Tygacil je bio jednako djelotvoran kao i usporedni antibiotici.
English: In the studies of abdominal infection, around 86% of the patients receiving either Tygacil or imipenem/cilastatin were cured.
Croatian: U ispitivanjima abdominalnih infekcija, izliječeno je otprilike 86 % bolesnika koji su primili ili lijek Tygacil ili imipenem/cilastatin.
English: In the other two studies, Tygacil was compared with imipenem/cilastatin (a combination of two medicines used together as an antibiotic) in 1,568 patients with complicated infections in the abdomen.
Croatian: Tygacil je uspoređen s imipenemom/cilastatinom (kombinacijom dva lijeka koja se koriste zajedno kao antibiotik) u 1 568 bolesnika s kompliciranim infekcijama u abdomenu.
English: Tygacil is a powder that is made up into a solution for infusion (drip into a vein).
Croatian: Tygacil je prašak od kojeg se radi otopina za infuziju (drip u venu).
English: What is Tygacil?
Croatian: Što je Tygacil?
English: The most common side effects with Tygacil are mild to moderate nausea (feeling sick) and vomiting, seen in 20% and 14% of patients, respectively.
Croatian: Najčešće su nuspojave povezane s lijekom Tygacil blaga do umjerena mučnina (osjećaj slabosti) i povraćanje, uočeno u 20 % odnosno 14 % bolesnika.
English: In the studies of skin and soft tissue infections, around 86% of the patients receiving Tygacil were cured, compared with around 89% of those receiving vancomycin and aztreonam.
Croatian: U ispitivanjima kožnih infekcija i infekcija mekanog tkiva, izliječeno je otprilike 86 % bolesnika koji su primali lijek Tygacil, u usporedbi s 89 % onih koji su primili vankomicin i aztreonam.
English: An additional study compared Tygacil with the antibiotic ertapenem in 813 diabetic patients with moderate to severe foot infections.
Croatian: Dodatna ispitivanja usporedila su Tygacil s antibiotikom ertapenemom u 813 bolesnika s dijabetesom s umjerenim do ozbiljnim infekcijama stopala.
English: How does Tygacil work?
Croatian: Kako djeluje Tygacil?
English: In two of these studies, Tygacil was compared with the combination of vancomycin and aztreonam in 1,129 patients with complicated skin and soft tissue infections (not including infected diabetic foot ulcers).
Croatian: Tygacil je uspoređen s kombinacijom vankomicina i aztreonama u 1 129 bolesnika s kompliciranim kožnim infekcijama i infekcijama mekog tkiva (isključujući čireve na inficiranim stopalima dijabetičara).
English: ‘Complicated' means that the infection is difficult to treat.
Croatian: Koristi se i za liječenje kompliciranih infekcija u abdomenu. „Komplicirane” znači da se infekcija teško liječi.
English: What benefit has Tygacil shown during the studies?
Croatian: Koje su koristi lijeka Tygacil utvrđene u ispitivanjima?
English: What is Tygacil used for?
Croatian: Za što se Tygacil koristi?
English: How is Tygacil used?
Croatian: Kako se Tygacil koristi?
English: For the full list of all side effects reported with Tygacil, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Tygacil potražite u uputi o lijeku.
English: How has Tygacil been studied?
Croatian: Kako je Tygacil ispitivan?
English: It is given six to nine times a day.
Croatian: Daje se šest do devet puta na dan.
English: This summary was last updated in 02-2014.
Croatian: Sažetak je posljednji put ažuriran: 02-2014.
English: The main measure of effectiveness was the number of patients who had responded to treatment after 12 weeks.
Croatian: Glavna mjera djelotvornosti bio je broj bolesnika koji su reagirali na liječenje nakon 12 tjedana.
English: As the company had supplied the additional information requested at the time of authorisation, the ‘exceptional circumstances' ended on 26 August
Croatian: Nakon što je tvrtka dostavila dodatne informacije zatražene u vrijeme odobenja, „iznimne okolnosti" prestale su postojati 26. kolovoza 2013.
English: The recommended dose is 2.5 or 5 micrograms.
Croatian: Preporučena je doza 2,5 ili 5 mikrograma.
English: The full EPAR for Ventavis can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: If the patient has liver or kidney problems, the time between doses should be at least three to four hours.
Croatian: Ako bolesnik ima problema s bubrezima ili jetrom, vrijeme između doziranja treba biti najmanje tri do četiri sata.
English: Ventavis was significantly more effective than placebo: 17% of the patients taking Ventavis responded to treatment (17 out of 101), compared with 5% of the patients taking placebo (5 out of 102).
Croatian: Ventavis je bio znatno djelotvorniji od placeba: Sedamnaest posto bolesnika koji su uzimali Ventavis reagiralo je na liječenje (17 od 101), u usporedbi s 5 % bolesnika koji su uzimali placebo (5 od 102).
English: The dose should be reduced to 2.5 micrograms again if the patient cannot tolerate the higher dose.
Croatian: Dozu treba opet smanjiti na 2,5 mikrograma ako bolesnik ne može podnijeti višu dozu.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Ventavis on 16 September 2003.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje za Ventavis vrijedi na prostoru Europske unije od 16. rujna 2003.
English: By dilating these blood vessels, the blood pressure is reduced and symptoms are improved.
Croatian: Širenjem tih krvnih žila smanjuje se tlak, a simptomi ublažavaju.
English: This is a summary of the European public assessment report (EPAR) for Ventavis.
Croatian: Ovo je sažetak Europskoga javnog izvješća o ocjeni (EPAR) za lijek Ventavis.
English: A ‘response' was defined as a combination of a 10% improvement in exercise capacity (measured by looking at how far the patient could walk in six minutes) and an improvement of the patient's condition (the severity of the disease going down by at least one class), without a worsening of pulmonary hypertension or death.
Croatian: „Odgovor” se definira kao kombinacija poboljšanja od 10 % u kapacitetu tjelesne aktivnosti (mjeri se tako da se promatra koliko bolesnik može prehodati u 6 minuta) i poboljšanje bolesnikova stanja (težina bolesti mora se smanjiti barem za jednu klasu), bez pogoršanja plućne hipertenzije ili smrti.
English: Patients should start with the low dose of 2.5 micrograms for the first inhalation, and if the first dose is well tolerated, the second and consecutive doses should be 5 micrograms.
Croatian: Bolesnici trebaju započeti s niskom dozom od 2,5 mikrograma za prvu inhalaciju te ako se prva doza dobro podnosi, iduća i sve ostale doze trebaju iznosi 5 mikrograma.
English: What measures are being taken to ensure the safe and effective use of Ventavis?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Ventavis ?
English: The medicine must be given using a type of nebuliser known as a ‘dosimetric' nebuliser, which stops automatically when the correct dose has been delivered.
Croatian: Lijek treba davati pomoću vrste atomizatora koji je poznat kao „dozimetrijski” atomizator koji se automatski zaustavlja nakon primjene točne doze.
English: Treatment with Ventavis should be started and monitored by a doctor experienced in the treatment of pulmonary hypertension.
Croatian: Liječenje lijekom Ventavis treba započeti i nadzirati liječnik iskusan u liječenju plućne hipertenzije.
English: For more information about treatment with Ventavis, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Ventavis pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: However, when looking at different groups of patients in this study, a benefit of Ventavis that would be relevant for patients was only shown in patients with class III primary pulmonary hypertension.
Croatian: Međutim, kada se promatraju različite skupine bolesnika u ovom ispitivanju, korist od lijeka Ventavis koja bi bila relevantna za bolesnike utvrđena je samo za bolesnike s klasom III primarne plućne hipertenzije.
English: Other information about Ventavis
Croatian: Ostale informacije o lijeku Ventavis